Patents by Inventor Stefan Wöll

Stefan Wöll has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091312
    Abstract: The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as pancreatic cancer and metastases thereof.
    Type: Application
    Filed: August 24, 2023
    Publication date: March 21, 2024
    Inventors: Ugur Sahin, Özlem Türeci, Rita Mitnacht-Kraus, Stefan Wöll, Stefan Jacobs, Cornelia Heinz
  • Patent number: 11919951
    Abstract: The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN6 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN6.
    Type: Grant
    Filed: February 7, 2022
    Date of Patent: March 5, 2024
    Assignees: Astellas Pharma Inc., TRON-Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
    Inventors: Rita Mitnacht-Kraus, Stefan Wöll, Korden Walter, Özlem Türeci, Ugur Sahin
  • Publication number: 20220162302
    Abstract: The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN6 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN6.
    Type: Application
    Filed: February 7, 2022
    Publication date: May 26, 2022
    Inventors: Rita MITNACHT-KRAUS, Stefan WÖLL, Korden WALTER, Özlem TÜRECI, Ugur SAHIN
  • Patent number: 11279757
    Abstract: The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN6 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN6.
    Type: Grant
    Filed: September 5, 2018
    Date of Patent: March 22, 2022
    Assignees: Astellas Pharma Inc., TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige Gmbh
    Inventors: Rita Mitnacht-Kraus, Stefan Wöll, Korden Walter, Özlem Türeci, Ugur Sahin
  • Publication number: 20200199221
    Abstract: The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN6 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN6.
    Type: Application
    Filed: September 5, 2018
    Publication date: June 25, 2020
    Inventors: Rita MITNACHT-KRAUS, Stefan WÖLL, Korden WALTER, Özlem TÜRECI, Ugur SAHIN
  • Publication number: 20180119146
    Abstract: The present invention relates to the identification of nucleic acid and amino acid sequences that are characteristic of tumor tissues such as ovarian tumor and lung tumor tissues and which represent targets for therapy or diagnosis of tumor diseases in a subject.
    Type: Application
    Filed: October 5, 2017
    Publication date: May 3, 2018
    Inventors: Ugur Sahin, Özlem Türeci, Michael Koslowski, Gerd Helftenbein, Korden Walter, Stefan Wöll, Gabriela-Elena Oprea
  • Patent number: 9809815
    Abstract: The present invention relates to the identification of nucleic acid and amino acid sequences that are characteristic of tumor tissues such as ovarian tumor and lung tumor tissues and which represent targets for therapy or diagnosis of tumor diseases in a subject.
    Type: Grant
    Filed: February 19, 2010
    Date of Patent: November 7, 2017
    Assignees: GANYMED PHARMACEUTICALS AG, JOHANNES GUTENBERG-UNIVERSITAT MAINZ
    Inventors: Ugur Sahin, Özlem Türeci, Michael Koslowski, Gerd Helftenbein, Korden Walter, Stefan Wöll, Gabriela-Elena Oprea
  • Patent number: 9512232
    Abstract: The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
    Type: Grant
    Filed: May 6, 2013
    Date of Patent: December 6, 2016
    Assignees: GANYMED PHARMACEUTICALS AG, TRON—Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
    Inventors: Ugur Sahin, Özlem Türeci, Rita Mitnacht-Kraus, Stefan Wöll
  • Patent number: 9139172
    Abstract: A method and an apparatus for controlling the speed of a motor vehicle in particular during a hill ascent are described. In a PID controller acting upon the brake system of the motor vehicle the change of the vehicle inclination is fed into the I branch of the controller, thereby providing an adaptive speed control.
    Type: Grant
    Filed: February 6, 2008
    Date of Patent: September 22, 2015
    Assignee: Lucas Automotive GmbH
    Inventors: Thomas Bach, Michael Bleser, Elmar Hoffmann, Stefan Wöll, Harald Thelen
  • Publication number: 20150147763
    Abstract: The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing cancer and/or in determining whether cancer cells express CLDN18.2.
    Type: Application
    Filed: May 6, 2013
    Publication date: May 28, 2015
    Inventors: Ugur Sahin, Özlem Türeci, Rita Mitnacht-Kraus, Stefan Wöll
  • Publication number: 20140127219
    Abstract: The present invention provides antibodies useful as therapeutics for treating and/or preventing diseases associated with cells expressing CLDN6, including tumor-related diseases such as ovarian cancer, lung cancer, gastric cancer, breast cancer, hepatic cancer, pancreatic cancer, skin cancer, malignant melanoma, head and neck cancer, sarcoma, bile duct cancer, cancer of the urinary bladder, kidney cancer, colon cancer, placental choriocarcinoma, cervical cancer, testicular cancer, and uterine cancer.
    Type: Application
    Filed: April 20, 2012
    Publication date: May 8, 2014
    Applicants: JOHANNES GUTENBERG-UNIVERSITÄT MAINZ, GANYMED PHARMACEUTICALS AG
    Inventors: Ugur Sahin, Ozlem Tureci, Michael Koslowski, Korden Walter, Stefan Wöll, Maria Kreuzberg, Bernd Hubner, Michael Erdeljan, Michael Weichel
  • Patent number: 8332119
    Abstract: A system for a hill descent control in the braking equipment of a motor vehicle comprising an electrically controllable service brake system, which is designed both for an anti-locking control function and for a braking function irrespective of actuation by the driver, a brake actuator which permits an individual adjustment of the braking pressures or braking moments generated for the individual wheels of a motor vehicle, which are the respective manipulated variables controlled by the hill descent control, an electronic control unit being provided for the electronic control and/or regulation which directly or indirectly detects variables related to operating conditions of the motor vehicle and adjusts additional braking moments when driving on steeply inclined roads, irrespective of whether a brake pedal is actuated.
    Type: Grant
    Filed: August 21, 2006
    Date of Patent: December 11, 2012
    Assignee: Lucas Automotive GmbH
    Inventors: Thomas Bach, Michael Bleser, Elmar Hoffmann, Stefan Wöll, Harald Thelen
  • Publication number: 20110300144
    Abstract: The present invention relates to the identification of nucleic acid and amino acid sequences that are characteristic of tumor tissues such as ovarian tumor and lung tumor tissues and which represent targets for therapy or diagnosis of tumor diseases in a subject.
    Type: Application
    Filed: February 19, 2010
    Publication date: December 8, 2011
    Inventors: Ugur Sahin, Ozlem Tureci, Michael Koslowski, Gerd Helftenbein, Korden Walter, Stefan Wöll, Gabriela-Elena Oprea
  • Publication number: 20110010065
    Abstract: A method and an apparatus for controlling the speed of a motor vehicle in particular during a hill ascent are described. In a PID controller acting upon the brake system of the motor vehicle the change of the vehicle inclination is fed into the I branch of the controller, thereby providing an adaptive speed control.
    Type: Application
    Filed: February 6, 2008
    Publication date: January 13, 2011
    Inventors: Thomas Bach, Michael Bleser, Elmar Hoffmann, Stefan Wöll, Harald Thelen
  • Publication number: 20100217469
    Abstract: A system for a hill descent control in the braking equipment of a motor vehicle comprising an electrically controllable service brake system, which is designed both for an anti-locking control function and for a braking function irrespective of actuation by the driver, a brake actuator which permits an individual adjustment of the braking pressures or braking moments generated for the individual wheels of a motor vehicle, which are the respective manipulated variables controlled by the hill descent control, an electronic control unit being provided for the electronic control and/or regulation which directly or indirectly detects variables related to operating conditions of the motor vehicle and adjusts additional braking moments when driving on steeply inclined roads, irrespective of whether a brake pedal is actuated.
    Type: Application
    Filed: August 21, 2006
    Publication date: August 26, 2010
    Inventors: Thomas Bach, Michael Bleser, Elmar Hoffmann, Stefan Wöll, Harald Thelen